The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug

  • Nuria C Navarro Coy
  • , Sarah Brown
  • , Ailsa Bosworth
  • , Claire T Davies
  • , Paul Emery
  • , Colin C Everett
  • , Catherine Fernandez
  • , Janine C Gray
  • , Suzanne Hartley
  • , Claire Hulme
  • , Anne-Maree Keenan
  • , Christopher McCabe
  • , Anthony Redmond
  • , Catherine Reynolds
  • , David Scott
  • , Linda D Sharples
  • , Sue Pavitt
  • , Maya H Buch

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science